Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
Biokit

May 2026

Biokit Market Share Analysis for May 2026

Year Founded1974
Employees201 - 500
Annual Revenue$100M - $200M
biokit.com
Biokit
Biokit (including company regionals)
  • biokit.com
    biokit.com
See more website traffic and engagement information

Biokit Revenue up to May 2026 is 100M - 200M

revenue generated by Biokit top domains

Biokit top domains revenue over 3 years

Revenue for Biokit top domains


Total visits to Biokit's top domains

Understand Biokit market share and potential market reach.

Total visits last 3 months

No Data to Display

No Data to Display

Avg. visit duration in Biokit's top domains

Analyze Biokit engagement metrics.

Average visit duration last 3 months

No Data to Display

No Data to Display

Avg. pageviews on Biokit's top domains

See how Biokit keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

No Data to Display

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Biokit

These are the website technologies, by industry, used by Biokit top domains

Content Management System (3)

Drupal

Drupal

Widget (3)

Google Maps

Google Maps

Audio Video Media (2)

VideoJS

VideoJS

Conversion & Analytics (2)

Google Analytics

Google Analytics

More Technologies

7

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Biokit

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAvacta Group partnered with Biokit on Mar 9th '21.Avacta, the developer of cancer therapies and diagnostics based on its Affimer and pre|CISION platforms, has entered into a license agreement with Biokit to incorporate Affimer reagents into a Biokit in-vitro diagnostic (IVD) product.

See all Biokit signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.